Ugma Laboratories Private Limited
About Ugma Laboratories Private Limited
Data last updated:
Ugma Laboratories Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 20 November 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24236UP1981PTC005476. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹13.73 Lakh. It is led by directors including Madhu Bhargava and Shivani Bvhargava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/295 Civil Lines Kanpur, Uttar Pradesh, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹30,300, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹1,300 (net margin 4.3%) and EBITDA of ₹1,300 (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹17 Lakh and satisfied charges of ₹52.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address15/295 Civil Lines Kanpur, Uttar Pradesh, India
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Ugma Laboratories Private Limited FY 2025 filings available
Ugma Laboratories Private Limited reported revenue of ₹30,300 (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ugma Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 1% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ugma Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1,300 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,300 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ugma Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ugma Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ugma Laboratories Private Limited
Ugma Laboratories has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Bhargava | Director | 01 Jan 2003 | 23 Years 9 Months | Current |
| Shivani Bvhargava Also directs: Ankur Pharmaceuticals Private Limited | Director | 18 Nov 2017 | 8 Years 11 Months | Current |
| Swatantra Bhargava | Director | 03 Jun 2021 | 5 Years 4 Months | Current |
| Sandeep Bhargava Also directs: Ankur Pharmaceuticals Private Limited | Director | 03 Jun 2021 | 5 Years 4 Months | Current |
Auditor Details of Ugma Laboratories Private Limited
Ugma Laboratories Private Limited is audited by GUPTA AGARWAL & SULTANIA for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GUPTA AGARWAL & SULTANIA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ugma Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ugma Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Aug 2000 | Bank of Baroda | ₹14 Lakh | Open |
| 29 Apr 2000 | Bank of Baroda | ₹2 Lakh | Open |
| 11 Apr 1984 | Bank of Baroda | ₹1 Lakh | Open |
| 23 Apr 2002 | State Bank of India | ₹40 Lakh | Satisfied |
| 19 Jan 1995 | Bank of Baroda | ₹12.5 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Ugma Laboratories Private Limited
Employment history and EPFO contributions of people linked to Ugma Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ugma Laboratories Private Limited
Ugma Laboratories Private Limited has 8 board changes on record since 2003: 4 appointments and 4 cessations. The latest: Sandeep Bhargava ceased to be Additional Director on 30 Nov 2021.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ugma Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ugma Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ugma Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ugma Laboratories Private Limited
Ugma Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ugma Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ugma Laboratories Private Limited
Ugma Laboratories is an active private limited company based in Uttar Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 20 November 1981 (45+ years old) and is registered under CIN U24236UP1981PTC005476.
Ugma Laboratories reported revenue of ₹30,300 for FY 2024 (up 1% YoY).
Ugma Laboratories has 4 current directors:
- Madhu Bhargava - Director
- Shivani Bvhargava - Director
- Swatantra Bhargava - Director
- Sandeep Bhargava - Director
Ugma Laboratories reported a net profit of ₹1,300 (net margin 4.3%) and EBITDA of ₹1,300 (EBITDA margin 4.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ugma Laboratories is 3% over three years and 2% over five years. In the latest year (FY 2024) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
No. Ugma Laboratories has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ugma Laboratories is U24236UP1981PTC005476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ugma Laboratories was incorporated on 20 November 1981, making it 45+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Sandeep Bhargava ceased to be Additional Director on 30 Nov 2021. Swatantra Bhargava ceased to be Additional Director on 30 Nov 2021. Sandeep Bhargava was appointed as Director on 03 Jun 2021. Ugma Laboratories has 8 board changes on record in total.
The registered office of Ugma Laboratories is at 15295 Civil Lines Kanpur, Uttar Pradesh, India.